Intelligent Bio Solutions (NASDAQ:INBS) Stock Price Up 0.3%
Intelligent Bio Solutions (NASDAQ:INBS) Stock Price Up 0.3%
Intelligent Bio Solutions Inc. (NASDAQ:INBS – Get Rating)'s stock price rose 0.3% during trading on Tuesday . The stock traded as high as $6.42 and last traded at $5.93. Approximately 28,133 shares changed hands during trading, a decline of 88% from the average daily volume of 242,778 shares. The stock had previously closed at $5.91.
智能生物科技股份有限公司（NASDAQ：INBS — 獲得評級）週二交易期間股價上漲了 0.3%。該股價高達 6.42 美元，最後交易價格為 5.93 美元。約 28,133 股股份在交易過程中轉手，較每日平均成交量 242,778 股下跌 88%。該股票之前已收盤 5.91 美元。
Intelligent Bio Solutions Stock Performance
智能生物解決方案股票表
The stock has a 50 day simple moving average of $2.84. The company has a current ratio of 1.32, a quick ratio of 1.19 and a debt-to-equity ratio of 0.14.
該股票有一個 50 天的簡單移動平均線 2.84 美元。該公司的流動比率為 1.32，快速比率為 1.19，債務與權益比率為 0.14。
Intelligent Bio Solutions (NASDAQ:INBS – Get Rating) last announced its quarterly earnings results on Tuesday, February 14th. The company reported ($0.46) EPS for the quarter. Intelligent Bio Solutions had a negative return on equity of 65.81% and a negative net margin of 421.22%. The company had revenue of $0.63 million for the quarter. Analysts predict that Intelligent Bio Solutions Inc. will post -6.6 earnings per share for the current fiscal year.
智能生物解決方案（NASDAQ：INBS-獲取評級）上週二公佈了其季度盈利業績，週二，2 月 14 日。該公司報告了本季度每股盈利 (0.46 美元)。智能生物解決方案的負資產回報率為 65.81%，負淨利潤率為 421.22%。該公司本季度的收入為 0.63 萬美元。分析師預測，智能生物解決方案公司將在本財年公佈 -6.6 每股盈利。
About Intelligent Bio Solutions
關於智能生物方案
(Get Rating)
(取得評分)
Intelligent Bio Solutions Inc, a life sciences company, developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. It offers Saliva Glucose Biosensor, an organic thin-film transistor for diabetes management that measures glucose in saliva. The company also focuses on developing SARS-CoV-2 Biosensor, a biosensor test can be used as a complement to the (RNA) virus detection test; and a biosensor platform comprising of biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities.
Intelligent Bio Solutions Inc. 是一家生命科學公司，致力於為患者及其主要健康從業人員開發非侵入式實時監測和診斷測試。它提供唾液葡萄糖生物傳感器，這是一種用於糖尿病管理的有機薄膜晶體管，可測量唾液中的葡萄糖。該公司還專注於開發 SARS-CoV-2 Biosensor，該生物傳感器 test 可用作（RNA）病毒檢測 test 的補充；以及由生物化學，免疫學，腫瘤標誌物，激素和核酸診斷方式組成的生物傳感器平台。
Featured Stories
特色故事
- Get a free copy of the StockNews.com research report on Intelligent Bio Solutions (INBS)
- Fossil Group: Should You Bet On Consumer Discretionary In 2023?
- BJ's Wholesale Club Stock Moves Higher After Strong Results
- Monthly Realty Income is About to Get Bigger
- 3 Large Cap Dividend Challengers for Millennial Investors
- Sea Ltd Is On The Verge Of A 100% Rally, Should You Buy?
- 免費獲取有關智能生物解決方案研究報告的副本
- 化石集團：您應該在 2023 年押注自由消費嗎？
- BJ 批發俱樂部股票在強勁業績後走高
- 每月房地產收入即將變得更大
- 3 千禧一代投資者的大型股息挑戰者
- Sea 有限公司處於 100％ 拉力賽的邊緣，您應該購買嗎？
Receive News & Ratings for Intelligent Bio Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intelligent Bio Solutions and related companies with MarketBeat.com's FREE daily email newsletter.
每日接收智能生物解決方案的新聞和評分 -在下面輸入您的電子郵件地址，以通過 MarketBeat.com 的免費每日電子郵件通訊接收智能生物解決方案及相關公司的最新新聞和分析師評級的簡明每日摘要。
譯文內容由第三人軟體翻譯。